623 related articles for article (PubMed ID: 16710790)
1. Early self-reported impairments in arm functioning of primary breast cancer patients predict late side effects of axillary lymph node dissection: results from a population-based cohort study.
Albert US; Koller M; Kopp I; Lorenz W; Schulz KD; Wagner U
Breast Cancer Res Treat; 2006 Dec; 100(3):285-92. PubMed ID: 16710790
[TBL] [Abstract][Full Text] [Related]
2. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer.
Fleissig A; Fallowfield LJ; Langridge CI; Johnson L; Newcombe RG; Dixon JM; Kissin M; Mansel RE
Breast Cancer Res Treat; 2006 Feb; 95(3):279-93. PubMed ID: 16163445
[TBL] [Abstract][Full Text] [Related]
3. Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer.
Rietman JS; Geertzen JH; Hoekstra HJ; Baas P; Dolsma WV; de Vries J; Groothoff JW; Eisma WH; Dijkstra PU
Eur J Surg Oncol; 2006 Mar; 32(2):148-52. PubMed ID: 16387467
[TBL] [Abstract][Full Text] [Related]
4. Changes in arm morbidities and health-related quality of life after breast cancer surgery - a five-year follow-up study.
Sagen A; Kåresen R; Sandvik L; Risberg MA
Acta Oncol; 2009; 48(8):1111-8. PubMed ID: 19863218
[TBL] [Abstract][Full Text] [Related]
5. Predictors of lymphedema in patients with breast cancer undergoing axillary lymph node dissection in Hong Kong.
Mak SS; Yeo W; Lee YM; Mo KF; Tse KY; Tse SM; Ho FP; Kwan WH
Nurs Res; 2008; 57(6):416-25. PubMed ID: 19018216
[TBL] [Abstract][Full Text] [Related]
6. Subjective morbidity and quality of life after sentinel node biopsy and axillary lymph node dissection for breast cancer.
Barranger E; Dubernard G; Fleurence J; Antoine M; Darai E; Uzan S
J Surg Oncol; 2005 Oct; 92(1):17-22. PubMed ID: 16180226
[TBL] [Abstract][Full Text] [Related]
7. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer.
Rietman JS; Dijkstra PU; Geertzen JH; Baas P; de Vries J; Dolsma WV; Groothoff JW; Eisma WH; Hoekstra HJ
Ann Surg Oncol; 2004 Nov; 11(11):1018-24. PubMed ID: 15525832
[TBL] [Abstract][Full Text] [Related]
8. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial.
Del Bianco P; Zavagno G; Burelli P; Scalco G; Barutta L; Carraro P; Pietrarota P; Meneghini G; Morbin T; Tacchetti G; Pecoraro P; Belardinelli V; De Salvo GL;
Eur J Surg Oncol; 2008 May; 34(5):508-13. PubMed ID: 17614245
[TBL] [Abstract][Full Text] [Related]
9. Eighteen sensations after breast cancer surgery: a comparison of sentinel lymph node biopsy and axillary lymph node dissection.
Baron RH; Fey JV; Raboy S; Thaler HT; Borgen PI; Temple LK; Van Zee KJ
Oncol Nurs Forum; 2002 May; 29(4):651-9. PubMed ID: 12011912
[TBL] [Abstract][Full Text] [Related]
10. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
[TBL] [Abstract][Full Text] [Related]
11. [Arm morbidity after axillary dissection for breast cancer].
Stahlberg CI; Jørgensen T
Ugeskr Laeger; 2001 Jun; 163(24):3356-9. PubMed ID: 11434124
[TBL] [Abstract][Full Text] [Related]
12. Association between extent of axillary lymph node dissection and patient, tumor, surgeon, and hospital factors in patients with early breast cancer.
Petrik DW; McCready DR; Sawka CA; Goel V
J Surg Oncol; 2003 Feb; 82(2):84-90. PubMed ID: 12561062
[TBL] [Abstract][Full Text] [Related]
13. Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection--data from a prospective randomised trial.
Helms G; Kühn T; Moser L; Remmel E; Kreienberg R
Eur J Surg Oncol; 2009 Jul; 35(7):696-701. PubMed ID: 18838245
[TBL] [Abstract][Full Text] [Related]
14. Sentinel node biopsy and quality of life measures in a Chinese population.
Chen JJ; Huang XY; Liu ZB; Chen TW; Cheng JY; Yang WT; Xu WP; Shao ZM; Shen ZZ; Wu J
Eur J Surg Oncol; 2009 Sep; 35(9):921-7. PubMed ID: 19233602
[TBL] [Abstract][Full Text] [Related]
15. Implications of a postoperative rehabilitation program on quality of life in women with primary breast cancer treated with sentinel lymph node biopsy or complete axillary lymph node dissection.
Pinto e Silva MP; Sarian LO; Morais SS; Pace do Amaral MT; Freire de Oliveira MM; Derchain S
Ann Surg Oncol; 2008 Dec; 15(12):3342-9. PubMed ID: 18931880
[TBL] [Abstract][Full Text] [Related]
16. Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer.
Crane-Okada R; Wascher RA; Elashoff D; Giuliano AE
Ann Surg Oncol; 2008 Jul; 15(7):1996-2005. PubMed ID: 18415650
[TBL] [Abstract][Full Text] [Related]
17. Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy.
Nesvold IL; Dahl AA; Løkkevik E; Marit Mengshoel A; Fosså SD
Acta Oncol; 2008; 47(5):835-42. PubMed ID: 18568481
[TBL] [Abstract][Full Text] [Related]
18. Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma.
Rietman JS; Dijkstra PU; Geertzen JH; Baas P; De Vries J; Dolsma W; Groothoff JW; Eisma WH; Hoekstra HJ
Cancer; 2003 Aug; 98(4):690-6. PubMed ID: 12910511
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing arm and axillary symptoms after treatment for node negative breast carcinoma.
Yap KP; McCready DR; Narod S; Manchul LA; Trudeau M; Fyles A
Cancer; 2003 Mar; 97(6):1369-75. PubMed ID: 12627499
[TBL] [Abstract][Full Text] [Related]
20. Comparing patients' and clinicians' assessment of outcomes in a randomised trial of sentinel node biopsy for breast cancer (the RACS SNAC trial).
Smith MJ; Gill PG; Wetzig N; Sourjina T; Gebski V; Ung O; Campbell I; Kollias J; Coskinas X; Macphee A; Young L; Simes RJ; Stockler MR;
Breast Cancer Res Treat; 2009 Sep; 117(1):99-109. PubMed ID: 18925434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
